These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3604619)

  • 1. Bleeding after hip arthroplasty not increased by heparin plus dihydroergotamine.
    Christensen SW; Wille-Jørgensen P; Bjerg-Nielsen A; Hølmich P; Duus B
    Acta Orthop Scand; 1987 Apr; 58(2):104-5. PubMed ID: 3604619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement.
    Freick H; Haas S
    Thromb Res; 1991 Jul; 63(1):133-43. PubMed ID: 1658962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
    Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
    Lassen MR; Borris LC; Christiansen HM; Møller-Larsen F; Knudsen VE; Boris P; Nehen AM; de Carvalho A; Jurik AG; Nielsen BW
    Br J Surg; 1988 Jul; 75(7):686-9. PubMed ID: 2843255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusted subcutaneous heparin versus heparin plus dihydroergotamine in prevention of deep vein thrombosis after total hip arthroplasty.
    Leyvraz P; Bachmann F; Vuilleumier B; Berthet S; Bohnet J; Haller E
    J Arthroplasty; 1988; 3(1):81-6. PubMed ID: 3361324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.
    Haas S; Stemberger A; Fritsche HM; Welzel D; Wolf H; Lechner F; Blümel G
    Arzneimittelforschung; 1987 Jul; 37(7):839-43. PubMed ID: 2823840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results.
    Gallus AS; Cade JF; Mills KW; Murphy W
    Thromb Haemost; 1992 Sep; 68(3):238-44. PubMed ID: 1440484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].
    Weber U; Koppenhagen K; Mälzer H; Matthes M
    Langenbecks Arch Chir; 1991; 376(3):147-51. PubMed ID: 1651434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.
    Voth D; Schwarz M; Hahn K; Dei-Anang K; al Butmeh S; Wolf H
    Neurosurg Rev; 1992; 15(4):289-94. PubMed ID: 1336131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
    Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
    Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of deep venous thrombosis following total hip replacement, using epidural analgesia.
    Christensen SW; Wille-Jørgensen P; Bjerg-Nielsen A; Kjaer L
    Acta Orthop Belg; 1989; 55(1):58-61. PubMed ID: 2801064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee.
    JAMA; 1984 Jun; 251(22):2960-6. PubMed ID: 6371278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid Lomoparan and heparin-dihydroergotamine.
    Leyvraz P; Bachmann F; Bohnet J; Breyer HG; Estoppey D; Haas S; Hochreiter J; Jakubek H; Mair J; Sorensen R
    Br J Surg; 1992 Sep; 79(9):911-4. PubMed ID: 1422754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
    Comerota AJ; White JV
    Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Sasahara AA
    Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement.
    J Bone Joint Surg Am; 1989 Feb; 71(2):311-2. PubMed ID: 2918019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery].
    Voigt J; Hamelmann H; Hedderich J; Seifert J; Buchhammer T; Köhler A
    Zentralbl Chir; 1986; 111(21):1269-305. PubMed ID: 3544605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.